biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Johnny boy

<< Previous

Bullboard Posts

Next >>

Post by TheTruth1234on Jun 28, 2023 4:31pm

248 Views

Post# 35519297

Johnny boy

We know who Daniel is. We also know how his subscription service works.

Nice try.

We also know Dan didn't have to resort to gofundme page to finance Tailwinds, unlike you.

You have literally tried everything in your power to try to get people to your pathetic boomskid website, your stoxdotcom website etc. Posting little teasers and hooks here on Stockhouse to try to get traffic to you lame websites.

No one went, because no one cares what you have to say!

I think beenthere nailed it People only contacted you in hopes of getting info out of you, about Bioasis.
You were too narcissistic (or stupid) to realize that.

Where are they now? Where are all your "friends " Johnny boy??

Where are all your "resources "?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale